泌尿外科雷射市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

預計 2020 年泌尿外科雷射市場價值約為 9.4479 億美元，在預測期內以 5.51% 的複合年增長率增長。

預計 COVID-19 大流行將對市場增長產生重大影響。 冠狀病毒的公共衛生影響，加上幾乎完全暫停和取消外科手術的後果，對外科服務和有手術條件的患者產生了前所未有的影響。。 在高負擔地區，手術室和麻醉機已被呼吸輔助設備暫時取代。 此外，根據一項題為“因 COVID-19 大流行而取消擇期手術”的研究，“因 COVID-19 大流行而取消擇期手術。計劃報告稱，在 COVID 的高峰期中斷期間，近 250 萬例良性泌尿外科手術被取消-19大流行。 在未來幾週內，包括泌尿科醫生在內的醫護人員可能面臨越來越複雜的挑戰。 因此，應採用分流策略以避免浪費醫療資源。 在處理 COVID-19 患者時，還應堅持適當的保護政策以防止傳播。 由於上述因素，大流行可能對延期擇期手術研究市場產生短期負面影響。

推動市場發展的主要因素之一是世界泌尿系統疾病的高患病率。 女性尿失禁的患病率高於男性。 根據全球尿失禁論壇，2020 年，尿失禁影響了 4-8% 的人口，即全球近 4 億人的生活。 此外，在鈥和銩雷射治療系統中越來越多地採用微創手術是推動泌尿外科雷射市場的主要因素之一。 這些系統具有多項優勢，例如更高的效率、安全性和更快的恢復速度，從而增加了對銩和鈥系統的需求。

此外，雷射手術具有恢復快、住院時間短、失血少、切口小、全身疼痛小等優點。 因此，預計這些系統的可靠性和安全性將推動市場增長。 此外，所研究市場的主要參與者經常關注產品開發或批准，預計這將在預測期內顯著推動市場。 例如，2020 年 6 月，奧林巴斯宣布了 Soltive SuperPulsed 雷射系統（Soltive Laser System），這是一種銩光纖雷射技術的新應用，專為碎石術和軟組織應用而設計。 因此，預計這些因素將在預測期內推動市場增長。

泌尿外科雷射市場趨勢

良性前列腺增生症 (BPH) 有望成為泌尿外科雷射市場創收最高的應用領域

BPH 是一種涉及前列腺肥大的疾病，在男性中更為常見。 BPH 是由前列腺細胞不受控制的生長引起的非癌性前列腺增生。 與 BPH 相關的常見症狀包括尿頻、排尿困難、泌尿系統衰弱和無法排空膀胱。

由於BPH患者以老年人居多，隨著人口老齡化的加劇，這種疾病的負擔也在增加，從而增加了該領域對雷射治療的需求。 根據世界老齡化人口報告，到 2020 年，全球將有大約 7.27 億人生活在 65 歲及以上。 未來30年，這一老年人口將穩步增長，翻一番以上，預計到2050年將超過15億。 預計東亞和東南亞在未來幾年內的增長率將超過任何其他地區（約 3.12 億人）。 此外，全球老年人高風險膀胱癌負擔的增加也有望推動市場增長。

此外，根據 2020 年 5 月發表的一項題為“提示老年男性良性前列腺增生的下尿路症狀的患病率和相關因素”的研究，該病在老年人（70 歲）中的患病率更高。以上）最高，達到約 22.7%。 此外，正在研究幾種新的雷射療法以改善患者的治療效果。 例如，2020 年 12 月，澳大利亞聖文森特私立醫院的一組外科醫生正在研究一種基於虛擬籃子技術在意大利設計的 152 瓦雷射，用於治療良性前列腺增生症。 預計此類案例將支持市場的增長。

此外，隨著 COVID-19 後疫情的逐漸恢復，醫療保健提供者正在將重點轉移到 BPH 治療上，預計將以樂觀的態度積極合作治療 BPH。 . 這將促進所研究的市場。 因此，預計該細分市場在預測期內將實現強勁增長。

預計在預測期內北美將佔據重要的市場份額

北美目前在泌尿外科雷射設備市場佔據主導地位，並且由於尿石症、BPH 和其他泌尿外科相關疾病的增加，預計在未來幾年仍將佔據主導地位。 在美國，膀胱癌、尿失禁等泌尿外科疾病日益增多，微創手術因其手術時間短、並發症少而備受青睞，有望成為系統雷射市場中最大的市場。

在美國，新技術的出現和採用正在推動市場的增長。 不斷上漲的醫療費用是推動該國醫療保健行業增長的主要因素。 據美國癌症協會估計，2020 年美國將發生 81,400 例膀胱癌新病例（62,100 名男性和 19,300 名女性），約有 17,980 人死於該病。我知道這一點。

根據美國人口普查局 2019 年的估計，2018 年至 2019 年，65 歲及以上人口預計將增長 3.2%，從 2020 年的約 5600 萬增加到 2060 年的 9400 萬。 老年人往往容易患泌尿系統疾病，尤其是尿失禁，這推動了市場增長。 雷射療法似乎是治療女性尿失禁的一種很有前途的替代方法。 該國有一家歷史悠久的公司，不斷致力於新產品的開發。 2020年10月，奧林巴斯推出了Soltive SuperPulsed雷射系統（Soltive Laser System），專為碎石術和軟組織應用而設計的銩光纖雷射技術應用。 因此，上述因素有望促進該地區泌尿外科雷射市場的增長。

其他福利。

• Excel 格式的市場預測 (ME) 表
• 三個月的分析師支持

內容

第1章介紹

• 研究假設和市場定義
• 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

• 市場概覽
• 市場驅動因素
  • 泌尿系統疾病患病率增加
  • 技術進步
  • 對微創手術的需求不斷增長
• 市場製約因素
  • 雷射系統成本高
• 波特的五力分析
  • 新進入者的威脅
  • 買方/消費者議價能力
  • 供應商的議價能力
  • 替代品的威脅
  • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

• 按雷射類型
  • 鈥雷射系統
  • 二極管雷射系統
  • 銩雷射系統
  • 其他雷射類型
• 通過申請
  • 良性前列腺增生症
  • 尿石症
  • 非肌層浸潤□□性膀胱癌
  • 其他用途
• 按地區
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 中東
    • 海灣合作委員會
    • 南非
    • 其他中東地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲

第6章競爭格局

• 公司簡介
  • Allengers
  • Biolitec AG
  • Boston Scientific Corporation
  • Cook Group
  • El.En. Group
  • Lumenis
  • Medtronic
  • Olympus Corporation
  • OmniGuide Holdings Inc.
  • Richard Wolf GmbH
  • Surgical Lasers Inc.
  • Dornier MedTech

第7章 市場機會與今後動向

The urology laser market was valued at approximately USD 944.79 million in 2020 and is expected to record a CAGR of 5.51% over the forecast period.

The COVID-19 pandemic is expected to significantly impact the market's growth. In addition to the effects of the coronavirus on public health, there has been the collateral effect of near-universal disruption and cancelation of surgical services, which had unprecedented implications for surgical services and patients with surgical conditions. Operating theaters and anesthesia machines are being temporarily converted to respiratory support units in regions with a high disease burden. Additionally, as per the study titled, "Elective Surgery Cancellations due to the COVID-19 Pandemic: Global Predictive Modeling to Inform Surgical Recovery Plans," published in May 2020, approximately 2.5 million urological benign surgeries were reported to have been canceled during the peak disruption of the COVID-19 pandemic. Over the coming weeks, healthcare workers, including urologists, may face increasingly complex challenges. Thus, they should adopt the triage strategy to avoid wasting medical resources. They should also endorse good protection policies to guard against infection when dealing with COVID-19 patients. Owing to the abovementioned factors, the pandemic is likely to have a short-term negative impact on the market studied due to the postponed elective surgeries.

One of the major factors driving the market studied is the high prevalence of urologic conditions worldwide. The prevalence of urinary incontinence is higher in women than in men. According to the Global Forum on Incontinence, 2020, urinary incontinence affects between 4-8% of the population or the lives of almost 400 million people worldwide. Also, the rising adoption of minimally invasive surgical procedures in holmium systems and thulium laser treatment systems is one of the major factors propelling the market for urology lasers. These systems offer several benefits, such as greater efficiency, safety, and rapid recovery, resulting in increased demand for thulium and holmium systems.

Furthermore, laser procedures provide benefits such as faster recovery, shorter hospital stays, decreased blood loss, and lower overall body pain resulting from smaller incisions. Hence, these systems' reliability and safety features are expected to drive market growth. Additionally, key players in the market studied are focusing on frequent product developments and approvals, which is expected to substantially drive the market during the forecast period. For instance, in June 2020, Olympus launched its new Soltive SuperPulsed Laser System (Soltive Laser System), a new application of thulium fiber laser technology designed for stone lithotripsy and soft tissue applications. Thus, such factors are likely to drive the market's growth during the forecast period.

Urology Laser Market Trends

Benign Prostatic Hyperplasia (BPH) Expected to Generate Highest Revenue in the Application Segment of the Urology Laser Market

Benign prostatic hyperplasia is a medical condition involving the enlargement of the prostate gland, and it is highly prevalent in males. It is a non-cancerous growth of the prostate gland originating from the uncontrolled expansion of prostate cells. The common symptoms associated with BPH include frequent urination, urine initiation difficulties, a weak urinary system, and the inability to empty the urinary bladder.

The majority of the benign prostatic hyperplasia patient population is elderly, and as the geriatric population is growing, the burden of this disease is also increasing, boosting the demand for laser treatment in this segment. According to the World Ageing Population report, in 2020, around 727 million people aged 65 years and above were living across the world. Over the next three decades, this older population is expected to increase steadily and more than double, to reach over 1.5 billion by 2050. Eastern and South-eastern Asia are expected to observe the highest increase by about 312 million in the coming years compared to any other region. Moreover, the growing burden of bladder cancer globally, whose risk is higher among the elderly population, is also expected to boost the market growth.

Furthermore, according to the study titled, "The Prevalence and Associated Factors of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Aging Males," published in May 2020, disease prevalence was the highest in elderly patients (aged 70 years and above), amounting to about 22.7%. Several new laser treatments are also being studied to improve patient outcomes. For instance, in December 2020, a group of surgeons from St Vincent's Private Hospital, Australia, were working with a 152-watt laser based on virtual basket technology and designed in Italy to treat benign prostatic hyperplasia. Such instances are expected to support market growth.

Additionally, as the post-COVID-19 pandemic is gradually resuming, healthcare providers are shifting their focus toward BPH treatment, and an optimistic approach toward active collaboration for BPH treatments is expected. This will boost the market studied. Hence, positive growth is expected in this segment over the forecast period.

North America Expected to Hold Significant Market Share in the Forecast Period

North America currently dominates the market for urology laser devices and is expected to continue its stronghold for a few more years owing to the increasing prevalence of urolithiasis, BPH, and other urology-related disorders. The US is expected to be the largest market for urology lasers in the North American region owing to the increasing prevalence of urological disorders, such as bladder cancer and urinary incontinence, and the growing preference for minimally invasive procedures due to less operative time and fewer complications.

The emergence of novel technologies and their adoption is helping the market studied to grow in the US. Rising healthcare expenditure is the primary factor responsible for the growth of the healthcare sector in the country. According to the American Cancer Society, the estimated new cases of bladder cancer in Americans in 2020 were around 81,400 (men: 62,100, women: 19,300) and about 17,980 deaths occurred due to it in the US.

According to the US Census Bureau 2019 estimates, the population aged 65 years and above increased by 3.2% from 2018 to 2019, and it is expected to rise from around 56 million in 2020 to 94 million by 2060. The older population is often susceptible to urological diseases, especially urinary incontinence, which is propelling the market growth. Laser therapy seems to be a promising alternative approach to urinary incontinence in women. The country has well-established companies that are continuously engaged in developing new products. In October 2020, Olympus launched the Soltive SuperPulsed Laser System (Soltive Laser System) for the application of thulium fiber laser technology designed for stone lithotripsy and soft tissue applications. Hence, the aforementioned factors are expected to contribute to the growth of the urology laser market in the region.

Urology Laser Market Competitor Analysis

The urology laser market is moderately competitive and consists of several major players. In terms of market share, a few major players are currently dominating the market. Some of the companies currently dominating the market are Olympus Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Cook Group, Medtronic, Biolitec AG, and Lumenis Ltd. The key players are involved in various strategic alliances such as acquisitions, collaborations, and new product launches to withstand their position in the global market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increase in Prevalence of Urological Disorders
  • 4.2.2 Technological Advancements
  • 4.2.3 Rising Demand for Minimally Invasive Surgical Procedures
• 4.3 Market Restraints
  • 4.3.1 High Cost of Laser Systems
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

• 5.1 By Laser Type
  • 5.1.1 Holmium Laser System
  • 5.1.2 Diode Laser Systems
  • 5.1.3 Thulium Laser System
  • 5.1.4 Other Laser Types
• 5.2 By Application
  • 5.2.1 Benign Prostatic Hyperplasia
  • 5.2.2 Urolithiasis
  • 5.2.3 Non-Muscle-Invasive Bladder Cancer
  • 5.2.4 Other Applications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 US
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 UK
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Allengers
  • 6.1.2 Biolitec AG
  • 6.1.3 Boston Scientific Corporation
  • 6.1.4 Cook Group
  • 6.1.5 El.En. Group
  • 6.1.6 Lumenis
  • 6.1.7 Medtronic
  • 6.1.8 Olympus Corporation
  • 6.1.9 OmniGuide Holdings Inc.
  • 6.1.10 Richard Wolf GmbH
  • 6.1.11 Surgical Lasers Inc.
  • 6.1.12 Dornier MedTech

7 MARKET OPPORTUNITIES AND FUTURE TRENDS